Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Bortezomib chemotherapy can cause temporary skin rashes.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

M50054 may help treat hepatitis and hair loss from chemotherapy.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

MVP treatment is effective and safe for recurrent breast cancer.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Aumolertinib effectively controls lung cancer and improves quality of life.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.